Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

Ira M. Jacobson, Gregory J. Dore, Graham R. Foster, Michael Fried, Monica Radu, V. V. Rafalsky, Monika Peeters, Oliver Lenz, Sivi Ouwerkerk‐Mahadevan, Guy De La Rosa,

The Lancet · 2014 · 436 citations · 28 references

Concepts

References

28